Search results
Controlled human infection study paves the way to improving vaccines and therapeutics development
Medical Xpress· 12 hours agoThe research is published in The Lancet Microbe journal. People who do not have antibodies against a particular infectious agent are "seronegative" and those who have antibodies are called " ...
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 1 day agoThe session consisted of speakers showcasing breakthroughs in vaccine development across a variety...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 21 hours agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Analyst Report: Moderna, Inc.
Morningstar Research via Yahoo Finance· 5 hours agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID& ...
TIME100 Health: Katalin Kariko and Drew Weissman
Time via Yahoo News· 14 hours agoBut that recognition didn’t come for another 15 years, in the middle of the COVID-19 pandemic, when researchers realized that their discovery was the key...
Vaccine Against Urinary Tract Infections in Development
Medscape· 2 days agoA randomized study published in 2022 showed the vaccine's efficacy in preventing urinary tract...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 14 hours agoCompany Overview Founded in 2010 and public since December 2018, Moderna is a leader in mRNA...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 19 hours agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 billion in the same ...
Pfizer profits drop on lower Covid-19 product sales
Digital Journal· 2 days agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 2 days agoIt would produce half a billion doses of its Covid-19 vaccine annually, it said. “This is major,”...
